Pulmonary hemosiderosis in children with Down syndrome: a national experience - Archive ouverte HAL Access content directly
Journal Articles Orphanet Journal of Rare Diseases Year : 2018

Pulmonary hemosiderosis in children with Down syndrome: a national experience

(1) , (1) , (2) , (3, 4) , (5, 6) , (7) , (8, 9) , (10) , (11) , (12, 13) , (12, 13) , (14, 15) , (16, 17) , (18, 19) , (20) , (21, 22) , (23) , (2) , (1) , (1, 24, 25) , (1) , (26) , (1, 27, 25) , (1, 24, 25) , (1, 27, 25)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Jessica Taytard
  • Function : Author
  • PersonId : 947113
Isabelle Gibertini
  • Function : Author
  • PersonId : 930590

Abstract

BACKGROUND: Pulmonary hemosiderosis is a rare and complex disease in children. A previous study from the French RespiRare® network led to two important findings: 20% of the children presented with both pulmonary hemosiderosis and Down syndrome (DS), and at least one tested autoantibody was found positive in 50%. This study investigates the relationships between pulmonary hemosiderosis and DS.METHODS: Patients younger than 20 years old and followed for pulmonary hemosiderosis were retrieved from the RespiRare® database. Clinical, biological, functional, and radiological findings were collected, and DS and non-DS patients' data were compared.RESULTS: A total of 34 patients (22 girls and 12 boys) were included, among whom nine (26%) presented with DS. The mean age at diagnosis was 4.1 ± 3.27 years old for non-DS and 2.9 ± 3.45 years old for DS patients. DS patients tended to present a more severe form of the disease with an earlier onset, more dyspnoea at diagnosis, more frequent secondary pulmonary hypertension, and an increased risk of fatal evolution.CONCLUSIONS: DS patients have a higher risk of developing pulmonary hemosiderosis, and the disease seems to be more severe in this population. This could be due to the combination of an abnormal lung capillary bed with fragile vessels, a higher susceptibility to autoimmune lesions, and a higher risk of evolution toward pulmonary hypertension. A better screening for pulmonary hemosiderosis and a better prevention of hypoxia in DS paediatric patients may prevent a severe evolution of the disease.
Fichier principal
Vignette du fichier
13023_2018_Article_806.pdf (855.98 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-01823418 , version 1 (26-06-2018)

Identifiers

Cite

Aurelia Alimi, Jessica Taytard, Rola Abou Taam, Véronique Houdouin, Aude Forgeron, et al.. Pulmonary hemosiderosis in children with Down syndrome: a national experience. Orphanet Journal of Rare Diseases, 2018, 13 (1), pp.60. ⟨10.1186/s13023-018-0806-6⟩. ⟨inserm-01823418⟩
255 View
183 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More